| Intraperitoneal cisplatin and paclitaxel in ovarian cancer DK Armstrong, B Bundy, L Wenzel, HQ Huang, R Baergen, S Lele, ... New England Journal of Medicine 354 (1), 34-43, 2006 | 3318 | 2006 |
| Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients H Hampel, W Frankel, J Panescu, J Lockman, K Sotamaa, D Fix, ... Cancer research 66 (15), 7810-7817, 2006 | 722 | 2006 |
| Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) KS Tewari, MW Sill, RT Penson, H Huang, LM Ramondetta, LM Landrum, ... The Lancet 390 (10103), 1654-1663, 2017 | 659 | 2017 |
| Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based … M Markman, PY Liu, S Wilczynski, B Monk, LJ Copeland, RD Alvarez, ... Journal of Clinical Oncology 21 (13), 2460-2465, 2003 | 543 | 2003 |
| Dostarlimab for primary advanced or recurrent endometrial cancer MR Mirza, DM Chase, BM Slomovitz, R dePont Christensen, Z Novák, ... New England Journal of Medicine 388 (23), 2145-2158, 2023 | 499 | 2023 |
| Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer KS Tewari, RA Burger, D Enserro, BM Norquist, EM Swisher, MF Brady, ... Journal of Clinical Oncology 37 (26), 2317-2328, 2019 | 467 | 2019 |
| Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology RJ Morgan, DK Armstrong, RD Alvarez, JN Bakkum-Gamez, K Behbakht, ... Journal of the National Comprehensive Cancer Network 14 (9), 1134-1163, 2016 | 346 | 2016 |
| HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients C Morrison, V Zanagnolo, N Ramirez, DE Cohn, N Kelbick, L Copeland, ... Journal of Clinical Oncology 24 (15), 2376-2385, 2006 | 310 | 2006 |
| Sexual self-schema and sexual morbidity among gynecologic cancer survivors. BL Andersen, XA Woods, LJ Copeland Journal of consulting and clinical psychology 65 (2), 221, 1997 | 258 | 1997 |
| Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images JD Seidman, RA Soslow, R Vang, JJ Berman, MH Stoler, ME Sherman, ... Human pathology 35 (8), 918-933, 2004 | 224 | 2004 |
| Surgical staging for patients presenting with grade 1 endometrial carcinoma I Ben-Shachar, J Pavelka, DE Cohn, LJ Copeland, N Ramirez, ... Obstetrics & Gynecology 105 (3), 487-493, 2005 | 221 | 2005 |
| HER-2/neu amplification and overexpression in endometrial carcinoma CD Rolitsky, KS Theil, VR McGaughy, LJ Copeland, TH Niemann International journal of gynecological pathology 18 (2), 138-143, 1999 | 211 | 1999 |
| Borderline ovarian tumors: key points and workshop summary SG Silverberg, DA Bell, RJ Kurman, JD Seidman, J Prat, BM Ronnett, ... Human pathology 35 (8), 910-917, 2004 | 199 | 2004 |
| Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer JH Jacob, DM Gershenson, M Morris, LJ Copeland, TW Burke, ... Gynecologic oncology 42 (2), 146-150, 1991 | 196 | 1991 |
| Uterine endolymphatic stromal myosis: a collaborative study MS Piver, FN Rutledge, L Copeland, K Webster, L Blumenson, O Suh Obstetrics & Gynecology 64 (2), 173-178, 1984 | 185 | 1984 |
| Secondary cytoreductive surgery for recurrent epithelial ovarian cancer M Morris, DM Gershenson, JT Wharton, LJ Copeland, CL Edwards, ... Gynecologic oncology 34 (3), 334-338, 1989 | 182 | 1989 |
| Fallopian tube carcinoma GL Eddy, LJ Copeland, DM Gershenson, EN Atkinson, JT Wharton, ... Obstetrics & Gynecology 64 (4), 546-552, 1984 | 181 | 1984 |
| Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study LM Landrum, J Java, CA Mathews, GS Lanneau Jr, LJ Copeland, ... Gynecologic oncology 130 (1), 12-18, 2013 | 174 | 2013 |
| Ovarian cancer, version 2.2013 RJ Morgan, RD Alvarez, DK Armstrong, RA Burger, L Chen, L Copeland, ... Journal of the National Comprehensive Cancer Network 11 (10), 1199-1209, 2013 | 162 | 2013 |
| Clear cell carcinoma of the ovary: a study of 59 cases MA Crozier, LJ Copeland, EG Silva, DM Gershenson, CA Stringer Gynecologic oncology 35 (2), 199-203, 1989 | 162 | 1989 |